Long-term differential changes in mouse intestinal metabolomics after γ and heavy ion radiation exposure

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Cheema, Amrita K ^a   Suman, Shubhankar ^a   Kaur, Prabhjit ^a   Singh, Rajbir ^a   Fornace Jr , Albert J ^a,b   Datta, Kamal ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINO ACID; BIOLOGICAL MARKER; DIPEPTIDE; GUANOSINE; ICOSANOID; INOSINE; IRON; NUCLEOTIDE; PROSTANOID; URIDINE;

AMINO ACID METABOLISM; ANALYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COSMIC RADIATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GAMMA RADIATION; HEAVY ION RADIATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; INGENUITY PATHWAY ANALYSIS; INTESTINE; INTESTINE ABSORPTION; LIPOGENESIS; LONG TERM EXPOSURE; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; NUTRIENT UPTAKE; PROTEIN METABOLISM; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INJURY; RADIOTHERAPY; RISK ASSESSMENT; SIGNAL TRANSDUCTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH ELECTROSPRAY QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

AMINO ACIDS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION; HEAVY IONS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINES; MASS SPECTROMETRY; METABOLOMICS; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL;

EID: 84899951499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087079     Document Type: Article

References (95)

1. Hamilton SA, Pecaut MJ, Gridley DS, Travis ND, Bandstra ER, et al. (2006) A murine model for bone loss from therapeutic and space-relevant sources of radiation. J Appl Physiol 101:789-793. (Pubitemid 44352290)
2. Hayatsu K, Hareyama M, Kobayashi S, Yamashita N, Sakurai K, et al. (2009) HZE Particle and Neutron Dosages from Cosmic Rays on the Lunar Surface. J. Phys. Soc. Jpn. 78:149-152.
3. Brooks A, Bao S, Rithidech K, Couch LA, Braby LA (2001) Relative effectiveness of HZE iron-56 particles for the induction of cytogenetic damage in vivo. Radiat Res 155:353-359. (Pubitemid 32125987)
4. Curtis SB, Townsend LW, Wilson JW, Powers-Risius P, Alpen EL, et al. (1992) Fluence-related risk coefficients using the Harderian gland data as an example. Adv Space Res 12:407-416.
5. Datta K, Neumann RD, Winters TA (2005) Characterization of complex apurinic/apyrimidinic-site clustering associated with an authentic site-specific radiation-induced DNA double-strand break. Proc Natl Acad Sci U S A 102:10569-10574. (Pubitemid 41061595)
6. Hada M, Sutherland BM (2006) Spectrum of complex DNA damages depends on the incident radiation. Radiat Res 165:223-230. (Pubitemid 43153135)
7. Cucinotta FA, Wu H, Shavers MR, George K (2003) Radiation dosimetry and biophysical models of space radiation effects. Gravit Space Biol Bull 16:11-18.
8. Farthmann EH, Imdahl A, Eggstein S (1994) Radiation enteropathy. Strahlenther Onkol 170:437-440. (Pubitemid 24270886)
9. Johnson LB, Riaz AA, Adawi D, Wittgren L, Back S, et al. (2004) Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model. BMC Surg 4:10.
10. Rosen IB, Shapiro BJ (1964) Radiation enteropathy of the small bowel. Can Med Assoc J 91:681-688.
11. Datta K, Suman S, Kallakury BV, Fornace AJJ (2012) Exposure to heavy ion radiation induces persistent oxidative stress in mouse intestine. PLoS One 7:e42224.
12. Datta K, Suman S, Trani D, Doiron K, Rotolo JA, et al. (2012) Accelerated hematopoietic toxicity by high energy (56)Fe radiation. Int J Radiat Biol 88:213-222.
13. Suman S, Datta K, Trani D, Laiakis EC, Strawn SJ, et al. (2012) Relative biological effectiveness of (12)C and (28)Si radiation in C57BL/6J mice. Radiat Environ Biophys
14. Patterson AD, Li H, Eichler GS, Krausz KW, Weinstein JN, et al. (2008) UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal Chem 80:665-674. (Pubitemid 351206854)
15. Okunieff P, Chen Y, Maguire DJ, Huser AK (2008) Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev 27:363-374.
16. Coy SL, Cheema AK, Tyburski JB, Laiakis EC, Collins SP, et al. (2011) Radiation metabolomics and its potential in biodosimetry. Int J Radiat Biol 87:802-823.
17. Ressom HW, Xiao JF, Tuli L, Varghese RS, Zhou B, et al. (2012) Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta 743:90-100.
18. Sheikh KD, Khanna S, Byers SW, Fornace AJ, Cheema AK (2011) Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome. J Biomol Tech 22:1-4.
19. Kaur P, Rizk N, Ibrahim S, Luo Y, Younes N, et al. (2013) Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes. Mol Biosyst 9:307-317.
20. Ghosh SP, Singh R, Chakraborty K, Kulkarni S, Uppal A, et al. (2013) Metabolomic changes in gastrointestinal tissues after whole body radiation in a murine model. Mol Biosyst 9:723-731.
21. Patterson AD, Lanz C, Gonzalez FJ, Idle JR (2010) The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev 29:503-521.
22. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJJ, et al. (2008) Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res 170:1-14. (Pubitemid 351931182)
23. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJJ, et al. (2009) Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res 172:42-57.
24. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, et al. (1998) The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106 Suppl 1:289-295. (Pubitemid 28196053)
25. Garrett WS, Gordon JI, Glimcher LH (2010) Homeostasis and inflammation in the intestine. Cell 140:859-870.
26. Podolsky DK (1991) Inflammatory bowel disease (1). N Engl J Med 325:928-937.
27. Podolsky DK (1991) Inflammatory bowel disease (2). N Engl J Med 325:1008-1016.
28. Dey I, Lejeune M, Chadee K (2006) Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 149:611-623. (Pubitemid 44748054)
29. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362-366. (Pubitemid 28047080)
30. Liu T, Laidlaw TM, Feng C, Xing W, Shen S, et al. (2012) Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation. Proc Natl Acad Sci U S A 109:12692-12697.
31. Sandig H, Pease JE, Sabroe I (2007) Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J Leukoc Biol 81:372-382. (Pubitemid 46198387)
32. Tessner TG, Muhale F, Schloemann S, Cohn SM, Morrison AR, et al. (2004) Ionizing radiation up-regulates cyclooxygenase-2 in I407 cells through p38 mitogen-activated protein kinase. Carcinogenesis 25:37-45. (Pubitemid 38128617)
33. Obenaus A, Huang L, Smith A, Favre CJ, Nelson G, et al. (2008) Magnetic resonance imaging and spectroscopy of the rat hippocampus 1 month after exposure to 56Fe-particle radiation. Radiat Res 169:149-161. (Pubitemid 351295072)
34. Peng Y, Brown N, Finnon R, Warner CL, Liu X, et al. (2009) Radiation leukemogenesis in mice: loss of PU.1 on chromosome 2 in CBA and C57BL/6 mice after irradiation with 1 GeV/nucleon 56Fe ions, X rays or gamma rays. Part I. Experimental observations. Radiat Res 171:474-483.
35. Tucker JD, Marples B, Ramsey MJ, Lutze-Mann LH (2004) Persistence of chromosome aberrations in mice acutely exposed to 56Fe+26 ions. Radiat Res 161:648-655. (Pubitemid 39149573)
36. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
37. Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, et al. (2011) Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res 175:473-484.
38. Sieber M, Hoffmann D, Adler M, Vaidya VS, Clement M, et al. (2009) Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci 109:336-349.
39. Zhou B, Wang J, Ressom HW (2012) MetaboSearch: tool for mass-based metabolite identification using multiple databases. PLoS One 7:e40096.
40. Shillingford JM, Piontek KB, Germino GG, Weimbs T (2010) Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol 21:489-497.
41. Skaland I, Janssen EA, Gudlaugsson E, Klos J, Kjellevold KH, et al. (2007) Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age. Mod Pathol 20:1307-1315. (Pubitemid 350126856)
42. Hunter MH, Sterrett JJ (2000) Polycystic ovary syndrome: it's not just infertility. Am Fam Physician 62:1079-88, 1090.
43. Drafta DS, Stroe E, Schindler EE, Teodosiu T, Gozariu L, et al. (1981) Adrenal function in early and metastatic breast cancer: dexamethasone suppression of plasma cortisol. Endocrinologie 19:115-121. (Pubitemid 11025291)
44. Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276-285. (Pubitemid 32108534)
45. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, et al. (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141:929-937.
46. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, et al. (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30. (Pubitemid 41095110)
47. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, et al. (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682-4688. (Pubitemid 37357512)
48. Pendyala L, Velagapudi S, Toth K, Zdanowicz J, Glaves D, et al. (1997) Translational studies of glutathione in bladder cancer cell lines and human specimens. Clin Cancer Res 3:793-798. (Pubitemid 27244348)
49. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457:910-914.
50. Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, et al. (2004) Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid. Cancer Epidemiol Biomarkers Prev 13:861-867. (Pubitemid 38737877)
51. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310:1504-1510. (Pubitemid 41746348)
52. Pugh S, Thomas GA (1994) Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut 35:675-678. (Pubitemid 24163797)
53. Maxwell WJ, Kelleher D, Keating JJ, Hogan FP, Bloomfield FJ, et al. (1990) Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinoma. Digestion 47:160-166.
54. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, et al. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328:1031-1035.
55. Lee MS, Moon EJ, Lee SW, Kim MS, Kim KW, et al. (2001) Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res 61:3290-3293. (Pubitemid 32695015)
56. Matsui Y, Amano H, Ito Y, Eshima K, Suzuki T, et al. (2012) Thromboxane A(2) receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells. Cancer Sci 103:700-707.
57. Dassesse T, de Leval X, de Leval L, Pirotte B, Castronovo V, et al. (2006) Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol 50:1021-31; discussion 1031.
58. Suman S, Johnson MD, Fornace AJJ, Datta K (2012) Exposure to ionizing radiation causes long-term increase in serum estradiol and activation of PI3K-Akt signaling pathway in mouse mammary gland. Int J Radiat Oncol Biol Phys 84:500-507.
59. Rola R, Sarkissian V, Obenaus A, Nelson GA, Otsuka S, et al. (2005) High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis. Radiat Res 164:556-560. (Pubitemid 41368936)
60. Tseng B, Giedzinski E, Izadi A, Suarez T, Lan M, et al. (2013) Functional consequences of radiation-induced oxidative stress in cultured neural stem cells and the brain exposed to charged particle irradiation. Antioxid Redox Signal
61. Snyder AR, Morgan WF (2004) Gene expression profiling after irradiation: clues to understanding acute and persistent responses? Cancer Metastasis Rev 23:259-268. (Pubitemid 38881810)
62. Cucinotta FA, Schimmerling W, Wilson JW, Peterson LE, Badhwar GD, et al. (2001) Space radiation cancer risks and uncertainties for Mars missions. Radiat Res 156:682-688. (Pubitemid 33027549)
63. Cucinotta FA, Durante M (2006) Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. Lancet Oncol 7:431-435.
64. Durante M, Cucinotta FA (2008) Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 8:465-472. (Pubitemid 351744960)
65. Laiakis EC, Hyduke DR, Fornace AJ (2012) Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors gamma radiation and lipopolysaccharide. Radiat Res 177:187-199.
66. Johnson CH, Patterson AD, Krausz KW, Kalinich JF, Tyburski JB, et al. (2012) Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat Res 178:328-340.
67. Vistad I, Kristensen GB, Fossa SD, Dahl AA, Morkrid L (2009) Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 73:1141-1147.
68. Caster WO, Armstrong WD (1956) Electrolyte metabolism after total-body x-irradiation. Radiat Res 5:189-204.
69. Snyder RD (1985) Effects of nucleotide pool imbalances on the excision repair of ultraviolet-induced damage in the DNA of human diploid fibroblasts. Basic Life Sci 31:163-173.
70. Hess JR, Greenberg NA (2012) The role of nucleotides in the immune and gastrointestinal systems: potential clinical applications. Nutr Clin Pract 27:281-294.
71. Mathews CK, Sinha NK (1982) Are DNA precursors concentrated at replication sites? Proc Natl Acad Sci U S A 79:302-306. (Pubitemid 12137706)
72. Liu H, Wang Z, Zhang X, Qiao Y, Wu S, et al. (2013) Selection of candidate radiation biomarkers in the serum of rats exposed to gamma-rays by GC/TOFMS-based metabolomics. Radiat Prot Dosimetry 154:9-17.
73. Lee do Y, Bowen BP, Nguyen DH, Parsa S, Huang Y, et al. (2012) Low-dose ionizing radiation-induced blood plasma metabolic response in a diverse genetic mouse population. Radiat Res 178:551-555.
74. Burns GA, Stephens KE (1995) Expression of mRNA for the N-methyl-D-aspartate (NMDAR1) receptor and vasoactive intestinal polypeptide (VIP) co-exist in enteric neurons of the rat. J Auton Nerv Syst 55:207-210.
75. Horio M, Ishima T, Fujita Y, Inoue R, Mori H, et al. (2013) Decreased levels of free D-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice. Neurochem Int 62:843-847.
76. Kim PM, Duan X, Huang AS, Liu CY, Ming GL, et al. (2010) Aspartate racemase, generating neuronal D-aspartate, regulates adult neurogenesis. Proc Natl Acad Sci U S A 107:3175-3179.
77. Fukunaga Y, Kimura M, Saitoh O (2010) NMDA receptor in intestinal enteroendocrine cell, STC-1. Neuroreport 21:772-776.
78. Costedio MM, Hyman N, Mawe GM (2007) Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum 50:376-388. (Pubitemid 46394454)
79. Hyland K (2007) Inherited disorders affecting dopamine and serotonin: critical neurotransmitters derived from aromatic amino acids. J Nutr 137:1568S-1572S; discussion 1573S.
80. Hubel KA (1976) Intestinal ion transport: effect of norepinephrine, pilocarpine, and atropine. Am J Physiol 231:252-257.
81. Aulsebrook KA (1965) intestinal absorption of glucose and sodium: effects of epinephrine and norepinephrine. Biochem Biophys Res Commun 18:165-169.
82. Munro AF (1951) The effect of adrenaline on the guinea-pig intestine. J Physiol 112:84-94.
83. Smith T, Ghandour MS, Wood PL (2011) Detection of N-acetyl methionine in human and murine brain and neuronal and glial derived cell lines. J Neurochem 118:187-194.
84. Steiber A, Kerner J, Hoppel CL (2004) Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25:455-473. (Pubitemid 39195071)
85. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576-585.
86. Holland RE, Rahman K, Morris AI, Coleman R, Billington D (1993) Effects of niacin on biliary lipid output in the rat. Biochem Pharmacol 45:43-49. (Pubitemid 23023739)
87. Peterson JW, Boldogh I, Popov VL, Saini SS, Chopra AK (1998) Anti-inflammatory and antisecretory potential of histidine in Salmonella-challenged mouse small intestine. Lab Invest 78:523-534.
88. van der Hulst RR, von Meyenfeldt MF, Deutz NE, Soeters PB (1997) Glutamine extraction by the gut is reduced in depleted [corrected] patients with gastrointestinal cancer. Ann Surg 225:112-121.
89. Sterner DE, Berger SL (2000) Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64:435-459. (Pubitemid 30412680)
90. Platt BS, Lu GD (1939) Studies on the metabolism of pyruvic acid in normal and vitamin B(1)-deficient states: The accumulation of pyruvic acid and other carbonyl compounds in beri-beri and the effect of vitamin B(1). Biochem J 33:1525-1537.
91. Gilliland IC, Martin MM (1951) Raised blood pyruvic acid level in diabetic acidosis; the value of cocarboxylase in treatment. Br Med J 1:14-16.
92. Zifroni A, Treves AJ, Sachar DB, Rachmilewitz D (1983) Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut 24:659-664. (Pubitemid 13066631)
93. Eberhart CE, Dubois RN (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285-301.
94. Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, et al. (2011) Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prev Res (Phila) 4:1198-1208.
95. Datta K, Suman S, Kallakury BV, Fornace AJJ (2013) Heavy ion radiation exposure triggered higher intestinal tumor frequency and greater beta-catenin activation than gamma radiation in APC(Min/+) mice. PLoS One 8:e59295.